Low Pain Prediction in Cesarean Section Patients

NCT02143141 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped feasibility of population needed to complete study

Conditions

Scheduled Cesarean Sections
Postoperative Pain Management
Side Effects

Interventions

DRUG: duramorph
DRUG: placebo

Sponsor

Wake Forest University Health Sciences